News List

My first! The GSK RSV vaccine has been approved by the FDA to be extended to age 50-59

On June 7, GlaxoSmithKline (GSK) announced that the FDA approved Arexvy, a recombinant respiratory s

Over $2 billion! Takeda introduces an anti-Aβ vaccine

On May 13, Takeda announced that it has entered into A worldwide exclusive option and license agreem

Astrazeneca's "first-in-class" oral small molecule is approved by the FDA

On April 1, 2024, Astrazeneca announced the FDA approval of its "first-in-class" oral smal

Nature Biotechnology | Antibody Drug Conjugators (ADCs) : ushering in a new era of precision cancer therapy

Recent studies have shown that by improving the linking technology and developing novel drug carrier

The oral version of Semaglutide was approved for domestic market, and clinical results showed that it can effectively reduce blood sugar and lose weight

On January 26, 2024, the official website of the State Food and Drug Administration showed that the

Semaglutide has a real rival! Lilly's strongest weight-loss drug, tilpotide is approved by the FDA

The FDA approved Tizepatide, developed by Eli Lilly and Company, as a weight loss drug (trade name Z

It can restore 80% hair growth, and Pfizer's new drug for alopecia areata was approved for sale in China, which can treat adolescent alopecia areata

On October 19, 2023, the official website of China's State Drug Administration showed that it ap

155 million dollars! Hengrui Medicine has another innovative drug to go to sea

Hengray Pharmaceutical announced that it has entered into an agreement with Dr. Reddy's Laborato

Bagel Biologics receives approval to initiate Phase I clinical trial of TCR cell therapy

On September 9, 2023, Biosyngen Pte Ltd (hereinafter referred to as "Biosyngen") announced

Researchers at Zhejiang University School of Medicine have revealed that the concept of targeting DDK can improve the efficacy of immunotherapy for liver cancer

Hepatocellular carcinoma is a common and highly aggressive tumor that has been recognized as the sev